Pharmaron Beijing Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 21,370 full-time employees. The company went IPO on 2019-01-28. Pharmaron Beijing Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The firm operates through five segments. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and cell and gene therapy products. The Chemical and Formulation Process Development and Manufacturing Services segment includes active pharmaceutical ingredient process development and manufacturing, as well as preformulation and formulation development. The Clinical Research Services segment includes international and domestic clinical research services. The Large Molecule and Cell and Gene Therapy Services segment includes large molecule drug discovery, development, and manufacturing services, as well as cell and gene therapy laboratory and gene therapy drug development and manufacturing services. The firm also operates through the others segment.
Follow-Up Questions
Pharmaron Beijing Co Ltd 的 CEO 是谁？
Mr. Boliang Lou 是 Pharmaron Beijing Co Ltd 的 Executive Chairman of the Board，自 2016 加入公司。
PHBBF 股票的价格表现如何？
PHBBF 的当前价格为 $0，在上个交易日 decreased 了 0%。
Pharmaron Beijing Co Ltd 的主要业务主题或行业是什么？
Pharmaron Beijing Co Ltd 属于 Life Sciences Tools & Services 行业，该板块是 Health Care
